It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
A Post Graduate in Science faculty and has a wide experience spanning over 35 years in the field of manufacturing Bulk Drugs and Active Pharmaceutical Intermediaries
BPDCN is a challenging blood cancer with characteristics of both leukemia and lymphoma
The Hub & Spoke model is designed to extend advanced medical care to a wider community
The platform integrates artificial intelligence into a unified environment that supports optical, microCT, ultrasound, and other imaging modalities
New infrastructure makes it possible for healthcare organizations to integrate AI agents seamlessly into critical workflows like benefit verification and prior authorization
The new site enables end-to-end production of viral vector gene therapies
Physician-led Pi Health has demonstrated capabilities to dramatically reduce clinical trial timelines and administrative burden, while increasing data quality
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
Subscribe To Our Newsletter & Stay Updated
